Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 11.06M $528.32M June 30, 2015
T. Rowe Price Associates 9.88M $392.25M March 31, 2015
BVF 5.93M $50.40M Dec. 31, 2011
OrbiMed Advisors 5.83M $231.65M March 31, 2015
Vanguard 5.36M $256.11M June 30, 2015
Perceptive Advisors 3.28M $156.87M June 30, 2015
BB Biotech AG 3.22M $153.86M June 30, 2015
BlackRock Fund Advisors 3.18M $151.65M June 30, 2015
PointState Capital 2.63M $104.57M March 31, 2015
Westfield Capital Management Company 2.29M $90.87M March 31, 2015
STATE STREET CORPORATION 2.04M $97.40M June 30, 2015
BlackRock Institutional Trust Company, N.A. 2.02M $96.67M June 30, 2015
Visium Asset Management 2.01M $95.86M June 30, 2015
VHCP Management 1.96M $26.29M June 30, 2013
Franklin Resources 1.93M $43.03M Dec. 31, 2014

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wellington Management Company June 30, 2011 1.93M $15.56M